Viatris Inc: Drug Recall

Recall #D-0203-2025 · 12/23/2024

Class II: Risk

Recall Details

Recall Number
D-0203-2025
Classification
Class II
Product Type
Drug
Recalling Firm
Viatris Inc
Status
Terminated
Date Initiated
12/23/2024
Location
Canonsburg, PA, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,215/30 count bottles

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Product Description

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

Distribution Pattern

USA nationwide.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.